Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

AstraZeneca extends oncology partnership with Proteros

Adding value through coaching

Accelerator aims to promote digital health innovation in Italy

Novel drug to tackle inflammatory diseases begins trial

AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial

immune thrombocytopenia

blood_cells1 1024x576

Market Access/ News/ News

Sobi gets EU nod for Doptelet in rare blood disorder ITP

Phil Taylor Doptelet, ema, Grifols, immune thrombocytopenia, Novartis, Promacta, rare disease, regulatory approval, Rigel Pharmaceuticals, SOBI 0 Comment

Sweden’s Sobi has secured EU approval for Doptelet in primary chronic immune thrombocytopenia (ITP), an indication that the

X

Sobi gets EU nod for Doptelet in rare blood disorder ITP

https://pharmaphorum.com/news/sobi-gets-eu-nod-for-doptelet-in-rare-blood-disorder-itp/

Sanofi Headquarters in Paris

News/ News/ R&D

FDA to expedite development of two Sanofi rare disease drugs

Richard Staines fda, immune thrombocytopenia, Pompe disease, R&D, Rare diseases, Sanofi 0 Comment

The FDA has agreed to expedite development of two rare disease drugs from Sanofi. The most significant of

X

FDA to expedite development of two Sanofi rare disease drugs

https://pharmaphorum.com/news/fda-to-expedite-development-of-two-sanofi-rare-disease/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval
AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial
Novel drug to tackle inflammatory diseases begins trial
Accelerator aims to promote digital health innovation in Italy
AstraZeneca extends oncology partnership with Proteros

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com